Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage.

Juvela S, Siironen J, Lappalainen J.

J Neurosurg. 2009 May;110(5):989-95. doi: 10.3171/2008.11.JNS081266. Erratum in: J Neurosurg. 2009 May;110(5):1042.

PMID:
19199499
2.

Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population.

Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H.

Stroke. 2000 Jun;31(6):1299-306. Erratum in: Stroke 2000 Sep;31(9):2279.

PMID:
10835448
4.

Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage.

Tang J, Zhao J, Zhao Y, Wang S, Chen B, Zeng W.

Surg Neurol. 2003 Nov;60(5):391-6; discussion 396-7.

PMID:
14572957
5.

Association of apolipoprotein E polymorphisms with cerebral vasospasm after spontaneous subarachnoid hemorrhage.

Wu HT, Zhang XD, Su H, Jiang Y, Zhou S, Sun XC.

Acta Neurochir Suppl. 2011;110(Pt 1):141-4. doi: 10.1007/978-3-7091-0353-1_24.

PMID:
21116929
6.

D-dimer as an independent predictor for poor outcome after aneurysmal subarachnoid hemorrhage.

Juvela S, Siironen J.

Stroke. 2006 Jun;37(6):1451-6. Epub 2006 May 11.

PMID:
16690901
7.

The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study.

Dunn LT, Stewart E, Murray GD, Nicoll JA, Teasdale GM.

Neurosurgery. 2001 May;48(5):1006-10; discussion 1010-1.

PMID:
11334266
8.

Psychosocial and neurocognitive performance after spontaneous nonaneurysmal subarachnoid hemorrhage related to the APOE-epsilon4 genotype: a prospective 5-year follow-up study.

Alfieri A, Unterhuber V, Pircher M, Schwarz A, Gazzeri R, Reinert M, Widmer HR.

J Neurosurg. 2008 Dec;109(6):1019-26. doi: 10.3171/JNS.2008.109.12.1019.

PMID:
19035714
9.

C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage.

Juvela S, Kuhmonen J, Siironen J.

Acta Neurochir (Wien). 2012 Mar;154(3):397-404. doi: 10.1007/s00701-011-1243-7. Epub 2011 Dec 3.

PMID:
22134501
10.

Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study.

Niskakangas T, Ohman J, Niemelä M, Ilveskoski E, Kunnas TA, Karhunen PJ.

Stroke. 2001 May;32(5):1181-4.

PMID:
11340230
11.

Risk factors for ischemic lesions following aneurysmal subarachnoid hemorrhage.

Juvela S, Siironen J, Varis J, Poussa K, Porras M.

J Neurosurg. 2005 Feb;102(2):194-201.

PMID:
15739544
12.

Lack of association between the apolipoprotein E gene and aneurysmal subarachnoid hemorrhage in an Italian population.

Fontanella M, Rainero I, Gallone S, Rubino E, Rivoiro C, Valfrè W, Garbossa D, Nurisso C, Ducati A, Pinessi L.

J Neurosurg. 2007 Feb;106(2):245-9.

PMID:
17410707
13.

Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.

Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES, Mayer SA.

Stroke. 2001 Sep;32(9):2012-20.

PMID:
11546890
14.

APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.

Lanterna LA, Rigoldi M, Tredici G, Biroli F, Cesana C, Gaini SM, Dalprà L.

Neurology. 2005 Apr 12;64(7):1238-44.

PMID:
15824354
15.

Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage.

Juvela S, Siironen J.

Eur J Neurol. 2012 Feb;19(2):332-9. doi: 10.1111/j.1468-1331.2011.03523.x. Epub 2011 Sep 27.

PMID:
21951336
16.

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Vergouwen MD, Frijns CJ, Roos YB, Rinkel GJ, Baas F, Vermeulen M.

Stroke. 2004 Jun;35(6):1280-3. Epub 2004 Apr 22.

PMID:
15105509
17.

Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage.

Leung CH, Poon WS, Yu LM, Wong GK, Ng HK.

Stroke. 2002 Feb;33(2):548-52.

PMID:
11823668
18.

Role of Apolipoprotein E Genotypes in Aneurysmal Subarachnoid Hemorrhage: Susceptibility, Complications, and Prognosis.

Hu X, Xie Z, Zan X, Ma L, Li H, You C, Jiang Y.

World Neurosurg. 2018 Oct;118:e666-e676. doi: 10.1016/j.wneu.2018.07.019. Epub 2018 Aug 12.

PMID:
30010064
19.

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage.

Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL.

Stroke. 2007 Aug;38(8):2315-21. Epub 2007 Jun 14.

PMID:
17569871
20.

Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia.

Lanterna LA, Ruigrok Y, Alexander S, Tang J, Biroli F, Dunn LT, Poon WS.

Neurology. 2007 Aug 21;69(8):766-75.

PMID:
17709709

Supplemental Content

Support Center